Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Tumor Cell Transdifferentiation via Transcription Factors
- Molecular classification
- Transcription factor
01
Overview
Tumor cell transdifferentiation, orchestrated by transcription factors, allows cancer cells to switch between differentiated states, acquiring new traits that promote tumor progression, metastasis, and therapy resistance. Transcription factors regulate gene expression and can reprogram cellular identity, often influenced by the tumor microenvironment and epigenetic remodeling. Targeting key transcription factors involved in malignant transdifferentiation offers a potential strategy for selective cancer therapy.
- Other names
- Cancer cell transdifferentiationTumor cell lineage plasticityTranscription factor-mediated cell reprogramming in cancer
02
Mechanism of action
Disruption of aberrant gene regulatory networks driving malignancy by targeting specific transcription factors.
03
Biological functions
Cell fate determinationGene expression regulationEpithelial-mesenchymal transition (EMT)Lineage plasticityStemness acquisitionCell proliferationCell migrationChromatin remodeling
04
Disease associations
Cancer progressionMetastasisTherapy resistanceTumor microenvironment modulation
05
Safety considerations
Off-target effects due to broad expression of some transcription factors in normal tissues.Development of resistance through compensatory mechanisms.Context-specific effects of transcription factor inhibition, requiring careful patient selection.Potential for toxicity related to disrupting fundamental cellular processes.
06
Interacting drugs
Small molecules targeting ligand-binding domains of transcription factors
2 more in the full profile.
07
Biomarkers
Expression levels of HMGA family membersExpression levels of FOXA family membersExpression levels of MRTFA/MKL1Expression levels of E2F family membersExpression levels of SIX family membersEMT markers (e.g., E-cadherin, Vimentin)Stemness markers (e.g., SOX2, OCT4)
Beyond the preview
Go deeper on Tumor Cell Transdifferentiation via Transcription Factors.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Tumor Cell Transdifferentiation via Transcription Factors.